Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Antibiotics: a risk factor for irritable bowel syndrome in a population-based cohort

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative colitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Minimally invasive assessment of hepatic function in children with indocyanine green elimination: a validation study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Long term treatment with stimulant laxatives - clinical evidence for effectiveness and safety?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Quality of life, performance status, and work capacity after post-endoscopic retrograde cholangiopancreatography pancreatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Microscopic colitis in Denmark and Sweden: incidence, putative risk factors, histological assessment and endoscopic activity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Evaluating next-generation sequencing for direct clinical diagnostics in diarrhoeal disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVES: Use of antibiotics affects the composition of the gut microbiome. The microbiome is thought to play a role in development of irritable bowel syndrome (IBS), but antibiotics as a possible risk factor for IBS has not been clarified. We aimed to explore if antibiotics is a risk factor for IBS by investigating use of antibiotics and development of IBS in a cohort from the Danish background population.

MATERIALS AND METHODS: An internet-based web panel representative of the Danish background population was invited to participate in a survey regarding the epidemiology of IBS in 2010, 2011 and 2013. A questionnaire based on the Rome III criteria for IBS were answered at all three occasions. In 2013, a question regarding use of antibiotics in the past year was included.

RESULTS: In 2013, use of antibiotics was reported by 22.4% (624/2781) of the population. A higher proportion of individuals with IBS reported use of antibiotics compared with asymptomatic controls [29.0% (155/534) vs. 17.9% (212/1,184), p < .01]. For asymptomatic respondents in 2010 and 2011 (n = 1004), the relative risk of IBS in 2013 related with use of antibiotics was 1.9 [95% confidence interval (CI): 1.1-3.1]. Adjusting for sex by logistic regression, development of IBS was predicted by use of antibiotics with an odds ratio of 1.8 (95% CI: 1.0-3.2).

CONCLUSIONS: Antibiotics is a risk factor for IBS in asymptomatic individuals. Possible mechanisms should be investigated in future studies.

OriginalsprogEngelsk
TidsskriftScandinavian Journal of Gastroenterology
Vol/bind53
Udgave nummer9
Sider (fra-til)1027-1030
ISSN0036-5521
DOI
StatusUdgivet - sep. 2018

ID: 55381651